Sandoz US Announces Precautionary Recall Of Oral Contraceptive Introvale®, Following Report Of Packa
date:Jun 07, 2012
rt the finding via the Sandoz Drug Information Direct Line at 800-525-2492, 24 hours/day, seven days a week, or via email atqa.druginfo@sandoz.com.
Patients or their healthcare provider may also report adverse reactions or quality problems experienced with the use of this product to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax as indicated below:

Online:http://www.fda.gov/medwatch/report.htm
Regular Mail: use postage-paid FDA form 3500 avai
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/03 17:48